7081.KLSE Pharmaniaga Bhd

Healthcare Health Care Providers & Services Kuala Lumpur Exchange
0.7900 MYR
Close of Oct 29, 2026
0.7750 1.60
Market cap
MYR 1.04B
P/E
6.1x
P/B
2.22x
ROE
19.2%
Dividend yield
2.48%
Fundamental score
1.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7081.KLSE undervalued?

Graham number
Price0.7900
Graham value1.02
Discount22.6%

7081.KLSE trades 22.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmaniaga Bhd fundamental analysis

9 of 22 checks passed

ROE 1/2

Moderate return on equity (19.2%), between 10% and 20%.

ROA 0/1

Return on assets (3.5%) is below the industry median (3.7%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-85.3%) is not above the 5-year average (26.2% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-85.3%) is below the industry median (6.1%).

Revenue Growth 1/2

Revenue grew 4.1% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

High debt to equity (170.3%), above 100%.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is 4.1x against interest expense, below 5x.

PE vs Market 1/1

PE (6.1x) is below the market median (11.4x).

PE vs Industry 1/1

PE (6.1x) is below the industry median (27.9x).

PBV 0/1

Price to book (2.2x) is above the industry median (2.2x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 13.5, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.23, growth is cheap.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About Pharmaniaga Bhd

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and de…

Full company profile